Browse Ophthalmic drugs topic

Subtopics (33)

• Cases
• Complications and side effects
• Conferences, meetings and seminars
• Distribution agreements
• Dosage and administration
• Evaluation
• Forecasts and trends
• Growth
• Health aspects
• Innovations
• Inspection
• Intellectual property
• International marketing
• Labeling
• Licensing agreements
• Market research
• Marketing
• Methods
• Packaging
• Physiological aspects
• Planning
• Product defects and recalls
• Product development
• Product information
• Product introduction
• Production processes
• Protection and preservation
• Quality management
• Reports
• Research
• Standards
• Statistics
• Usage

Articles

Title	Author	Type	Date	Words
Wedgewood Pharmacy Compounds Erythromycin, Critical Neonatal Medication, During Manufacturer Backorder.			Nov 12, 2009	546
Eye drug could stop excess hair.			Oct 20, 2009	132
Eye drug could stop excess hair.			Oct 20, 2009	133
Allergan Files Federal Lawsuit to Allow It to Share Relevant Information with the Medical Community on the Safe Use of BOTOX[R] for Common Therapeutic Off-Label Treatments.			Oct 2, 2009	2079
Allergan Announces Quarterly Conference Call.			Sep 30, 2009	224
Quintiles and Allergan Announce Co-Promotion for Sanctura XR[R].			Sep 25, 2009	1099
The Apothecary Shops Staffs Up to Fill Erythromycin Ophthalmic Ointment Shortage in U.S. Hospitals.			Sep 24, 2009	468
New eye drops could save sight of thousands.			Sep 21, 2009	168
pSivida CEO to Discuss New Technologies in Retinal Drug Delivery at 5th Annual Ophthalmic Drug Development and Delivery Summit.			Sep 18, 2009	683
AzaSite[R] Production Increased in Response to Erythromycin Ophthalmic Ointment Shortage.			Sep 14, 2009	979
Inspire Committed to Helping Healthcare Providers and Patients During Erythromycin Ophthalmic Ointment Shortage.			Sep 9, 2009	786
Research and Markets: Allergan: Performance, Products, Pipeline and Potential.			Aug 20, 2009	619
Alcon and AstraZeneca to Collaborate on Eye Drug Development.			Jul 22, 2009	737
Allergan Announces Quarterly Conference Call.			Jul 6, 2009	224
Vitamin A Eye Drops for Dry Eyes.	Gaby, Alan R.	Brief article	Jul 1, 2009	270
Allergan Receives FDA Approval for OZURDEX[TM] Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease.			Jun 18, 2009	1399
Dr. Paul Ashton, President/CEO of pSivida Corp and Internationally-Recognized Expert in Ophthalmic Drug Delivery Available for Comment on Allergan's FDA Approval of Ozurdex Today.			Jun 18, 2009	169
NanoViricides, Inc. Eye Drug Testing Has Begun.			Jun 15, 2009	780
Zacks Analyst Blog Highlights: D.R. Horton, Lennar, Weyerhaeuser, Owens Corning and Allergan, Inc.			May 29, 2009	695
Allergan Receives Complete Response Letter for BOTOX[R] (Botulinum Toxin Type A) for Treatment of Upper Limb Spasticity in Adults.			May 26, 2009	2016
Zacks Analyst Blog Highlights: Inspire Pharmaceuticals Inc., Allergan Inc., InSite Vision Incorporated, National Australia Bank Limited and Cypress Semiconductor.			May 15, 2009	811
Zacks Bull & Bear of the Day Highlights: SunPower, Salix Pharmaceuticals, Acadia Pharmaceuticals, Biovail and Allergan.			May 13, 2009	817
Allergan's Latisse Wishes is a new charitable public awareness campaign designed to generate $1 million for the Make-A-Wish Foundation.			May 1, 2009	158
Allergan Comments on Today's Follow up by the U.S. Food and Drug Administration (FDA) to Its Early Communication, Concluding the Agency's Safety Review of Botulinum Toxins.			May 1, 2009	1295
Allergan Comments on FDA Requested Class Labeling for Botulinum Toxin Treatments in Connection with Approval of DYSPORT[R].			Apr 30, 2009	1743
pSivida Corp. Technology Featured in Multiple Abstracts at ARVO Meeting.			Apr 23, 2009	887
Zacks Analyst Blog Highlights: California Pizza Kitchen, Inc., Bristol-Myers Squibb Co., Exelixis, ZymoGenetics and Allergan, Inc.			Apr 13, 2009	733
OTHERA Announces Positive Interim Phase 2 Results of OT-551 Eye Drop Treatment for Dry AMD.		Financial report	Apr 8, 2009	727
Agony of woman who mistook nail glue for eye drops.			Apr 3, 2009	473
Allergan Announces Quarterly Conference Call.			Apr 3, 2009	224
Fitch Revises Allergan's Rating Outlook to Stable; Affirms IDR at 'A-'.			Mar 31, 2009	553
SARcode Announces Results of Phase 1 Trial of SAR 1118 Ophthalmic Solution in Healthy Adult Subjects.			Mar 30, 2009	628
pSivida CEO to Present at IBC Ocular Angiogenesis Conference.		Conference news	Mar 27, 2009	612
Allergan Partners with Alorad and 3v07 in Ambitious Program to Make Things Easier for Women Considering Breast Augmentation.			Mar 26, 2009	730
InSite Vision Announces Restructuring to Support 2009 Strategic Priorities.			Mar 26, 2009	954
Coming soon: A drug that grows longer, thicker eyelashes.			Mar 19, 2009	182
Pfizer and Bausch & Lomb to Co-Promote Products for the Treatment of Ophthalmic Conditions.			Mar 3, 2009	539
Clinical Results with RegeneRx's Ophthalmic Drug Candidate Subject of Oral Presentation at 2009 ARVO Meeting.			Feb 23, 2009	740
Zacks Analyst Blog Highlights: Ctrip.com International, ViroPharma, Internap Network Services Corporation, Allergan, Inc. and Comstock Resources.			Feb 12, 2009	1038
NanoViricides, Inc. Update on Eye Drug Development.			Feb 9, 2009	824
Inspire Initiates Phase 3 Prolacria[TM] Dry Eye Trial under Special Protocol Assessment Agreement.			Jan 27, 2009	1098
Eye drops to blame, says asif.			Jan 25, 2009	244
Eye drops to blame, says asif.			Jan 24, 2009	244
Coming soon: A drug that grows longer, thicker eyelashes.			Jan 15, 2009	230
Zacks Analyst Blog Highlights: Inspire Pharmaceuticals, Inc., Allergan Pharmaceuticals, MarkWest Energy, The Boeing Company and Salesforce.com, Inc.			Jan 14, 2009	768
MacuCLEAR and Mystic Pharmaceuticals Agree To Collaborate on Macular Degeneration Phase I/II Clinical Trial.			Jan 13, 2009	457
Allergan Announces Quarterly Conference Call.			Jan 12, 2009	227
France : ExonHit extends drug discovery collaboration with Allergan.			Jan 8, 2009	271
Allergan Announces U.S. Food and Drug Administration (FDA) Approval of LATISSE[TM] -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes.			Dec 26, 2008	2206
InSite Vision Announces FDA Advisory Committee's Unanimous Recommendation of Approval for New Ophthalmic Product Enabled by InSite's DuraSite[R] Technology.			Dec 23, 2008	775
Research and Markets: Comprehensive Research on Pharmaceutical Company "Allergan, Inc and the U.S. Pharmaceutical Preparation Manufacturing Industry.			Dec 19, 2008	643
pSivida New Evaluation for Cardiovascular Drug Delivery.			Dec 16, 2008	742
Zacks Analyst Blog Highlights: Itron Inc., Akamai Technologies, Inc., Finisar Corp., Credit Suisse Group, or CSG and Allergan, Inc.		Company overview	Dec 15, 2008	996
Akorn, Inc. Announces FDA Approval of Ciprofloxacin HCl Ophthalmic Solution USP, 0.3%.			Dec 12, 2008	545
SARcode Announces Completion of Phase 1 Clinical Trial of SAR 1118 Ophthalmic Solution.			Dec 11, 2008	450
FDA Advisory Committee Recommends Approval of Bausch & Lomb Besifloxacin Anti-Infective Eye Drop.			Dec 5, 2008	227
FDA Advisory Committee Unanimously Recommends Approval of LATISSE[TM] (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes.			Dec 5, 2008	533
Spectrum Pharmaceuticals Announces Receipt of $41.5 Million from Allergan, Inc. Per Collaboration Agreement for Apaziquone Announced on October 29th.			Nov 6, 2008	638
Sweden: Polyphor signs licensing agreement with Allergan.			Nov 5, 2008	200
Zacks Analyst Blog Highlights: Cabela's Inc., Sanmina-SCI Corp., Dollar Financial Corp., Inspire Pharmaceuticals, Inc. and Allergan, Inc.			Nov 5, 2008	757
Polyphor to Enter into an Exclusive Agreement with Allergan for the Development of Protein Epitope Mimetics (PEM) Inhibitors for Ophthalmology.			Oct 31, 2008	402
Allergan, Inc. and Spectrum Pharmaceuticals, Inc. Announce Collaboration Agreement for Apaziquone (EOquin(R)).			Oct 29, 2008	1107
BAROnova Secures Investment From Allergan, Inc.			Oct 23, 2008	645
Inspire Announces Issuance of Patent for Elestat(R).			Oct 15, 2008	632
Allergan, Inc. and Clinique Announce Nationwide Availability of CLINIQUE MEDICAL.			Oct 15, 2008	1500
Inspire Initiates Phase 1 Trial of INS117548 For Glaucoma.			Oct 9, 2008	457
Zacks Analyst Blog Highlights: AutoNation, Inc., Oscient Pharmaceuticals Corp., Equity Residential, ACADIA Pharmaceuticals Inc. and Allergan, Inc.			Oct 3, 2008	840
Allergan Announces Quarterly Conference Call.			Oct 3, 2008	222
Zacks Analyst Blog Highlights: Burger King Holdings, Inc., McDonald's Corp., Allergan, Inc., AutoZone, Inc. and Hudson City Bancorp.			Sep 24, 2008	861
Inspire Initiates Special Protocol Assessment Process for Prolacria(TM) Trial for Dry Eye.			Sep 23, 2008	636
Allergan Announces Positive Top-Line Results from Phase III BOTOX(R) Headache Program.			Sep 11, 2008	1447
Inspire Announces Plans for Clinical Testing of New Compound INS117548 for the Treatment of Glaucoma.			Sep 11, 2008	693
Implant that will banish eye drops.			Sep 9, 2008	547
Asterand to Enter Into Exclusive License Agreement with Allergan for Pre-Clinical Compounds Focused on Diseases of the Eye.			Sep 8, 2008	758
More packaging flexibility in TEXAS: Allergan's single-use eye drop vials are packaged at their Waco, Texas plant, either in cartons of various sizes, or in hermetically sealed plastic trays. Previously, two separate packaging systems were used for this purpose, but in recent months the American company has implemented a GMP-compliant packaging line, which can do both.			Sep 1, 2008	1342
WALES: 'Postcode lottery' ends for eye drug; Pensioners hail move on sight-saving treatment.			Aug 28, 2008	466
India: Asterand enters exclusive license agreement with Allergan for eye treatments.			Aug 28, 2008	212
United States: Allergan nears closure of Fremont plant.			Aug 25, 2008	191
Research and Markets: Allergan Partnering Guide 2008 Is Intended to Provide the Reader With an In-Depth Understanding of the Partnering Activities and Interests of the Company.			Aug 14, 2008	464
Validity of Allergan Patents Acknowledged by Jan Marini in Settlement of Allergan's Patent Infringement Suit Against Jan Marini Skin Research, Inc.			Jul 18, 2008	634
China: China Medical Systems agrees exclusive distribution of Stulln eye drops in China.			Jul 18, 2008	136
NanoViricide's EKC Eye Drug Candidate Stopped Clinical Conjunctivitis Pathology.			Jul 14, 2008	782
Allergan v. Lancome Decision Clarifies Foreign-Based Trademark Registrations in Canada.			Jul 10, 2008	499
Meda: FDA Approves Azelastine Eye Drops Unit Dose.			Jul 8, 2008	173
Allergan Announces Quarterly Conference Call.			Jul 8, 2008	222
5 of the best Eye drops.			Jul 8, 2008	220
Support grows for free eye drug.			Jun 24, 2008	209
Is this how a war hero should be treated? echo 2 IT'S ALL ABOUT YOUR HEALTH Eileen Younghusband foiled Nazi bomb raids as a radar operator during World War II, but the 86-year-old heroine has now been caught up in a postcode lottery over eye drugs. She has been forced to use all her lifesavings to fund her battle against blindness - and she wants to know why.			Jun 19, 2008	769
Enbrel(R) (etanercept) Application for the Treatment of Pediatric Psoriasis to be Discussed at FDA Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting.			Jun 18, 2008	2126
Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting.			Jun 18, 2008	2670
Allergan Receives U.S. Food and Drug Administration Approval for TRIVARIS(TM) (triamcinolone acetonide injectable suspension) 80 mg/mL.			Jun 17, 2008	617
Zacks Analyst Blog Highlights: Lithia Motors, Ford, General Motors, Inspire Pharmaceuticals and Allergan Pharmaceuticals.			Jun 10, 2008	663
United States: Allergan Buys Acne Drug From QLT for $150 Million.			Jun 10, 2008	219
NanoViricides Inc. Posts Photos Showing Rapid Response of Animals to Treatment with EKC Eye Drug Candidate.			Jun 9, 2008	523
Allergan Announces Intent to File New Drug Application for Bimatoprost as Novel Treatment to Stimulate Natural Eyelash Growth.			Jun 4, 2008	664
BEWARE OF THE ELDERLY EYE DROPS.			Jun 3, 2008	353
NanoViricides in Discussions with Pharma about EKC Eye Drug Candidate.			May 28, 2008	627
Natural Ophthalmics eye drops.	Peterson, Eric	Brief article	May 1, 2008	137
Emedastine Difumarate Ophthalmic Solution.			Aug 1, 1998	768
Providing eye care education in the clinical setting.	Higgins, Leslie; Ambrose, Patricia	Report	Jun 1, 1995	3677